Frontiers in Pharmacology | Pharmacology of Anti-Cancer Drugs

Original Research

Published on 02 Oct 2024

The baseline hemoglobin level is a positive biomarker for immunotherapy response and can improve the predictability of tumor mutation burden for immunotherapy response in cancer

in Pharmacology of Anti-Cancer Drugs

Yin He
Tong Ren
Chengfei Ji
Li Zhao
Xiaosheng Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1456833

2,153 views
5 citations

Original Research

Published on 02 Oct 2024

Dehydroepiandrosterone suppresses human colorectal cancer progression through ER stress-mediated autophagy and apoptosis in a p53-independent manner

in Pharmacology of Anti-Cancer Drugs

Thi-Huong Nguyen
Huey-Jiun Ko
Po-Yu Tsai
Tai-Shan Cheng
Thu-Ha Tran
Ly Hien Doan
Michael Hsiao
Peter Mu-Hsin Chang
Hsiao-Sheng Liu
Yi-Ren Hong

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1464647

2,702 views
4 citations

Original Research

Published on 02 Oct 2024

DNA methylation inhibitors adverse reaction characteristic analysis: a descriptive analysis from WHO-VigiAccess

in Pharmacology of Anti-Cancer Drugs

Qiang Zhou
Quanlei Xie
Qiang Liu
Haojie Wang
Zhan Zhang
Zhao Yu
Qian Guo
Jie Lin

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1470148

2,820 views
3 citations

Mini Review

Published on 01 Oct 2024

Assessment of ferroptosis as a promising candidate for metastatic uveal melanoma treatment and prognostication

in Pharmacology of Anti-Cancer Drugs

Ellie Swords
Breandán N. Kennedy
Valentina Tonelotto

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1466896

2,724 views
1 citation

Review

Published on 01 Oct 2024

RGD-based self-assembling nanodrugs for improved tumor therapy

in Pharmacology of Anti-Cancer Drugs

Bin Wang
Dongmei Tang
Jianqiao Cui
Hongfei Jiang
Jing Yu
Zhu Guo

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1477409

3,538 views
4 citations

Review

Published on 30 Sep 2024

The role of SIRT1 in autophagy and drug resistance: unveiling new targets and potential biomarkers in cancer therapy

in Pharmacology of Anti-Cancer Drugs

Yujing Tang
Wantao Ju
Yanjun Liu
Qin Deng

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1469830

5,367 views
14 citations

Correction

Published on 30 Sep 2024

Corrigendum: Targeting p53 misfolding conundrum by stabilizing agents and their analogues in breast cancer therapy: a comprehensive computational analysis

in Pharmacology of Anti-Cancer Drugs

Burhan Ul Haq
Hina Qayoom
Shazia Sofi
Nusrat Jan
Aisha Shabir
Irshad Ahmad
Fuzail Ahmad
Abdullah Almilaibary
Manzoor A. Mir

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1494110

760 views

Original Research

Published on 27 Sep 2024

Interstitial lung disease associated with ALK inhibitors and risk factors: an updated comparative pharmacovigilance analysis

in Pharmacology of Anti-Cancer Drugs

Junli Dong
Lulu Li
Tiying Deng
Haibin Song
Shaohui Zhang
Minyu Zhong

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1361443

3,299 views
4 citations

Review

Published on 27 Sep 2024

Diversified applications of hepatocellular carcinoma medications: molecular-targeted, immunotherapeutic, and combined approaches

in Pharmacology of Anti-Cancer Drugs

Haoyang Chen
Huihui Liu
Xiaowei Zhang
Suhua Wang
Chunxia Liu
Ke An
Ruijuan Liu
Xin Tian

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1422033

2,478 views
2 citations

Perspective

Published on 26 Sep 2024

Erbin: an important therapeutic target for blocking tumor metastasis

in Pharmacology of Anti-Cancer Drugs

Tingting Qiu
Liquan Tan
Jialong Yan
Qunli Luo

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1474798

2,513 views
1 citation

Case Report

Published on 26 Sep 2024

A case report: deep and durable response to low-dose lenvatinib and tislelizumab in an elderly patient with advanced intrahepatic cholangiocarcinoma

in Pharmacology of Anti-Cancer Drugs

Pei Zhang
Xin Wang
Ruizhen Li
Xiaoying Li
Ke Cheng
Dan Cao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1447582

1,544 views

Original Research

Published on 25 Sep 2024

Global trends and topics in CDK7 inhibitor research: a bibliometric analysis

in Pharmacology of Anti-Cancer Drugs

Jiamin Liu
Ling He
Wenjing Jiang
Ping Xie

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1426988

3,290 views
3 citations

Original Research

Published on 24 Sep 2024

Ethnic sensitivity analyses of pharmacokinetics, efficacy and safety in polycythemia vera treatment with ropeginterferon alfa-2b

in Pharmacology of Anti-Cancer Drugs

Albert Qin
Daoxiang Wu
Jason Liao
Shuping Xie
Haoqi Chen
Yucheng Gao
Jie Cui
Xia Su
Narihisa Miyachi
Toshiaki Sato

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1455979

2,474 views
5 citations

Original Research

Published on 23 Sep 2024

Analysis of chromatin accessibility in peripheral blood mononuclear cells from patients with early-stage breast cancer

in Pharmacology of Anti-Cancer Drugs

Longjie Xia
Jiamin Lu
Yixuan Qin
Runchun Huang
Fanbiao Kong
Yu Deng

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1465586

1,938 views
1 citation

Review

Published on 20 Sep 2024

Advancing cancer therapy: new frontiers in targeting DNA damage response

in Pharmacology of Anti-Cancer Drugs

Jiekun Qian
Guoliang Liao
Maohui Chen
Ren-Wang Peng
Xin Yan
Jianting Du
Renjie Huang
Maojie Pan
Yuxing Lin
Xian Gong

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1474337

8,605 views
15 citations

Original Research

Published on 20 Sep 2024

Adverse event profile differences between pralsetinib and selpercatinib: a real-world study based on the FDA adverse events reporting system

in Pharmacology of Anti-Cancer Drugs

Qiong Jie
Yuanyuan Li
Li Jing
Jinjin Chen
Yang Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1424980

3,480 views
4 citations